3M CO
Other · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $24.95B | $24.57B | $24.61B | $26.16B | $35.35B | $8.07B |
| Operating income | $4.63B | $4.82B | −$10.69B | $4.37B | $7.37B | $7.16B |
| Net income | $3.25B | $4.17B | −$7.00B | $5.78B | $5.92B | $1.29B |
| Total assets | $37.73B | $39.87B | $50.58B | $46.45B | $47.07B | $47.34B |
| Total liabilities | $32.99B | $35.97B | $45.71B | $31.68B | $31.95B | $34.41B |
| Equity | $4.70B | $3.84B | $4.81B | $14.72B | $15.05B | $12.87B |
| EPS (diluted) | $6.00 | $7.55 | $-12.63 | $10.18 | $10.12 | $2.22 |
| Shares out. | 542.9M | 552.7M | 550.5M | 571.1M | 579.1M | 575.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 18.6%
- Net margin
- 13.0%
- Return on equity
- 69.1%
- Return on assets
- 8.6%
- Return on capital (ROCE)
- 16.5%
- Liabilities / assets
- 87.4%
- Debt / equity
- 7.02×
- Book value / share
- $8.66
- Revenue growth (YoY)
- 1.5%
- Net income growth (YoY)
- −22.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.46safe
- Accruals / assets
- 2.5%clean
- Beneish M-Score
- -2.27normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 6 good- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Jpmorgan Chase & CoPassive (13G)May 12, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 27, 2026
- Blackrock, Inc.Passive (13G)Apr 27, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- State Street CorpPassive (13G)Feb 4, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Sweet Thomas WDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Kereere SuzanDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Chow Anne HDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Brown Thomas KDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Fitterling James RDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Bozeman David PDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Choi AudreyDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Mitchill Neil G. JrDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Pizarro PedroDirector | May 12, 2026 | Grant | 1,360.402 | $143.34 |
| Reinseth Theresa EOfficer — Sr Vice President & CAO | May 1, 2026 | Option exercise | 1,441 | $142.50 |
| Brown William MOfficer — Chairman & CEO | May 1, 2026 | Option exercise | 8,578 | $142.50 |
| Banovetz John PatrickOfficer — Executive Vice President | May 1, 2026 | Option exercise | 13,420 | $142.50 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 13, 2026
- Entered a material agreement · New financial obligationMay 6, 2026
- Results of operationsApr 21, 2026
- Director / officer changeFeb 5, 2026
- Results of operationsJan 20, 2026
- Results of operationsOct 21, 2025
- Director / officer changeAug 15, 2025
- Results of operationsJul 18, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDMay 28, 2026
- 8-KMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- 4PRIMARY DOCUMENTMay 13, 2026
- SCHEDULE 13G/AMay 12, 2026
- SCHEDULE 13G/AMay 11, 2026
- SCHEDULE 13G/AMay 11, 2026
- SCHEDULE 13G/AMay 8, 2026
Corporate family
Spin-offs from 3M CO (1)
- Solventum CorpSOLVcompletedMar 26, 2024details
From the spin-off filings we track. Follow a company to walk its own history.